PedAM
Pediatric Disease Annotations & Medicines
| Disease | thromboembolism |
| Phenotype | C0011849|diabetes mellitus |
| Sentences | 4 |
| PubMedID- 23983579 | It can serve as a useful marker for the documentation of in vivo platelet activation, and thus, fore-warn the risk of thromboembolism in patients with diabetes mellitus, coronary syndromes, peripheral vascular diseases, and pre-eclampsia. |
| PubMedID- 22560173 | Venous thromboembolism in patients with diabetes mellitus. |
| PubMedID- 23457622 | Potential covariates were assessed based on known associations with ventricular size and heart disease, including demographics and anthropometric variables, as well as variables reflecting comorbidities and other characteristics (including systolic and diastolic blood pressure, hypertension, diabetes mellitus, history of venous thromboembolism, self-reported intentional exercise, use of anti-hypertensives, aspirin, statins, lipid-lowering therapy, hormone replacement therapy, hga1c, total cholesterol, low- and high-density lipoproteins, triglycerides, fasting glucose and insulin levels, serum il-6, c-reactive protein (crp), serum creatinine). |
| PubMedID- 26152296 | When analyzed as a continuous variable, duration of diabetes mellitus was associated with risk of thromboembolism in a dose-response-dependent manner, but not with a higher risk of bleeding during anticoagulant treatment. |
Page: 1